Soleno Therapeutics Inc’s filing revealed that its Shareholder Abingworth Bioventures VII LP acquired Company’s shares for reported $110.7 million on Aug 11 ’25. In the deal valued at $82.15 per share,1,347,522 shares were bought.
Then, Hirano Patricia C sold 3,830 shares, generating $316,971 in total proceeds. Upon selling the shares at $82.76, the insider now owns 13,206 shares.
Before that, PATRICIA HIRANO bought 3,830 shares. Soleno Therapeutics Inc shares valued at $316,971 were divested by the Officer at a price of $82.76 per share.
TD Cowen initiated its Soleno Therapeutics Inc [SLNO] rating to a Buy in a research note published on June 23, 2025; the price target was $110. Stifel also remained covering SLNO and reiterated its “Buy” recommendation on December 02, 2024. Robert W. Baird maintained its rating on December 02, 2024. It rated SLNO as “an Outperform”.
Price Performance Review of SLNO
On Friday, Soleno Therapeutics Inc [NASDAQ:SLNO] saw its stock fall -7.41% to $71.63. Over the last five days, the stock has lost -13.02%. Soleno Therapeutics Inc shares have risen nearly 44.65% since the year began. Nevertheless, the stocks have risen 59.35% over the past one year. While a 52-week high of $90.32 was reached on 07/09/25, a 52-week low of $41.50 was recorded on 01/15/25.
Levels Of Support And Resistance For SLNO Stock
The 24-hour chart illustrates a support level at 65.79, which if violated will result in even more drops to 59.95. On the upside, there is a resistance level at 75.14. A further resistance level may holdings at 78.65.
How much short interest is there in Soleno Therapeutics Inc?
A steep rise in short interest was recorded in Soleno Therapeutics Inc stocks on 2025-07-31, growing by 0.69 million shares to a total of 6.04 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-30 was 5.35 million shares. There was a rise of 11.37%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on September 03, 2024 when H.C. Wainwright began covering the stock and recommended ‘”a Buy”‘ rating along with a $70 price target.
